Here’s whether Avanos Medical, Inc. (AVNS) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+0.21% over 10 days); strong 1-year return of +110.3%. Concerns: RSI 77 — overbought, elevated pullback risk. Currently 2.0% off its 52-week high. Score: +4/7.
AVNS is in a confirmed uptrend, trading above both its 50-day ($24.90) and 200-day ($16.92) moving averages. With an RSI of 76.9, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +110.3% compares to +16.5% for SPY (beat the market by 93.9%).
$10,000 invested 1 year ago→ $21,035 today
vs. S&P 500 (SPY) — same period beat market by 93.9%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($16.92)
✓Above 50-day MA ($24.90)
!RSI(14) neutral zone (30–70) — currently 76.9
✓Positive return (+110.3%)
✓Within 10% of period high (−2.0%)
Period Range $24.99
$9.30$25.49
RSI (14) 76.9
0 · OversoldOverbought · 100
Key Metrics
Price$24.99
Period Return+110.3%
Period High$25.49
Period Low$9.30
Drawdown−2.0%
MA-50$24.90
MA-200$16.92
RSI (14)76.9
Avg Volume (30d)841K
vs. SPYbeat by 93.9%
Return Rank#101 of 999
Trend Signals
Price is above the 200-day moving average ($16.92)